Humanitas Global Health Announces Launch and LSU DeepDrug License Agreement at AAPS PharmSci 360
Humanitas Global Health debuts at the American Association of Pharmaceutical Scientists’ 2026 PharmSci 360 congress Humanitas Global Health, a mission-driven initiative applying explainable, traceable artificial intelligence and breakthrough science to reduce preventable suffering and improve access to better care. The company debuts at the American Association of Pharmaceutical Scientists’ 2026 PharmSci 360 conference in New Orleans. It hosts a panel discussion on translating artificial intelligence innovations into better care and enters into a license agreement with Louisiana State University to commercialize explainable artificial artificial intelligence platforms. The license agreement provides a foundation for Humanitas to commercialise DeepDrug technologies for pharmaceutical development and prescription safety. Humanitas also introduces EI, an approach to artificial intelligence that embeds ethical principles and respect for human dignity into system design.
发表 : 昨天 经过 Humanitas Global Health Inc. 在 Health Tech Science
Humanitas Global Health debuts at the American Association of Pharmaceutical Scientists’ 2026 PharmSci 360 congress
• Company hosts a panel discussion on translating artificial intelligence innovation... [5770 symbols]
话题: Louisiana State University, Academia
